Four-Year Safety Follow-Up of the Tetravalent Dengue Vaccine CYD-TDV

Clinical Microbiology and Infection - United Kingdom
doi 10.1016/j.cmi.2018.03.024
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus Naive Children

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2008English

Live Measles Vaccine: A 21 Year Follow Up.

BMJ
1987English

Live-Attenuated Tetravalent Dengue Vaccine Development at Mahidol University

The Bangkok Medical Journal
2016English

A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys Against All Four Serotypes of Dengue Virus

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2008English

Four-Year Follow-Up of Pregnancy-Associated Osteoporosis: A Case Report

Fukushima Journal of Medical Sciences
Medicine
2014English

Brazilian Hepatitis B Vaccine: A Six-Year Follow-Up in Adolescents

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2012English

Tetravalent Recombinant Dengue Virus-Like Particles as Potential Vaccine Candidates: Immunological Properties

BMC Microbiology
Microbiology
2014English

Phase I Trial of 16 Formulations of a Tetravalent Live-Attenuated Dengue Vaccine

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2003English

Simplified Treatment for Impacted Upper Canines: A Four-Year Follow-Up

RGO Revista Gaucha de Odontologia
Dentistry
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy